DECOMPENSATED LIVER CIRRHOSIS
Clinical trials for DECOMPENSATED LIVER CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new DECOMPENSATED LIVER CIRRHOSIS trials appear
Sign up with your email to follow new studies for DECOMPENSATED LIVER CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could growth factors help repair the liver in cirrhosis?
Disease control Recruiting nowThis pilot study tests whether giving a combination of two growth factors (G-CSF and darbepoetin) in single or repeated cycles can improve immune function in people with early decompensated cirrhosis. Sixty participants will be randomly assigned to receive either the growth facto…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New blood test could cut unnecessary transfusions in liver patients
Disease control Recruiting nowThis study compares a new method using ROTEM (a rapid blood clotting test) to standard care for deciding whether to give blood products before high-risk procedures in patients with decompensated liver cirrhosis. The goal is to see if the ROTEM-guided approach reduces the number o…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Phase: NA • Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a common cholesterol drug help slow liver failure?
Disease control Recruiting nowThis pilot study tests whether adding the statin atorvastatin to a standard beta blocker can help people with decompensated cirrhosis, a severe form of liver disease. Fifty participants will receive either atorvastatin plus their usual beta blocker or a placebo plus beta blocker,…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Phase: PHASE2 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Engineered immune cells aim to calm liver scarring in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver scarring (cirrhosis) that has led to complications. RTX001 uses the patient's own immune cells, modified in a lab to reduce inflammation and scarring. The trial will enroll 30 adults to check if the thera…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Shunt surgery may reverse liver failure in some cirrhosis patients
Disease control Recruiting nowThis study looks at whether a procedure called TIPS, which creates a bypass in the liver, can help people with advanced cirrhosis achieve 'recompensation' — meaning the liver partially recovers and complications ease. Researchers will follow 250 patients for one year after TIPS t…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New registry aims to sharpen TIPS patient selection for liver cirrhosis
Knowledge-focused Recruiting nowThis registry follows 250 patients with decompensated liver cirrhosis who receive a TIPS procedure, a shunt placed in the liver to reduce pressure. Researchers will track survival, brain function, nutrition, and quality of life over one year. The goal is to identify which patient…
Matched conditions: DECOMPENSATED LIVER CIRRHOSIS
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:34 UTC